At a Glance
Half Year Results for the Six Months Ended 31 December 2020
- Clinigen launches Managed Access Program with BeiGene for zanubrutinib 08 Apr 2021
- Clinigen to begin supplying Erwinase® in the UK 06 Apr 2021
- Clinigen Joins Decentralized Trials & Research Alliance (DTRA) 29 Mar 2021
The Group has a complementary portfolio of businesses operating globally, enhancing our ability to provide access to medicines worldwide.